Site characteristics during years 2–7 | Site-level participation by members | |||
---|---|---|---|---|
None/low Mean (SD) N = 47 (37.9%) | Moderate Mean (SD) N = 36 (29.0%) | High Mean (SD) N = 41 (33.1%) | P value | |
ACE inhibitor | 0.963 (0.057) | 0.963 (0.047) | 0.979 (0.021) | 0.198 |
Beta-blocker use* | 0.940 (0.067) | 0.946 (0.047) | 0.952 (0.044) | 0.565 |
Use of aldosterone antagonist* | 0.230 (0.146) | 0.254 (0.122) | 0.275 (0.124) | 0.301 |
Death 30 days after admission* | 0.068 (0.028) | 0.073 (0.031) | 0.062 (0.023) | 0.225 |
Death at 1 year after admission* | 0.297 (0.068) | 0.285 (0.051) | 0.278 (0.040) | 0.245 |
30-Day all-cause readmission following discharge with principal diagnosis of HF | 0.165 (0.041) | 0.177 (0.038) | 0.191 (0.024) | 0.005 |